250 related articles for article (PubMed ID: 17526378)
21. A potent weapon in the battle against HIV: your own immune system.
Proj Inf Perspect; 2002 Mar; (34):14-6. PubMed ID: 12038300
[TBL] [Abstract][Full Text] [Related]
22. From research tool to routine test: CD38 monitoring in HIV patients.
Coetzee LM; Tay SS; Lawrie D; Janossy G; Glencross DK
Cytometry B Clin Cytom; 2009 Nov; 76(6):375-84. PubMed ID: 19422053
[TBL] [Abstract][Full Text] [Related]
23. Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy?
Mastroianni CM; d'Ettorre G; Forcina G; Vullo V
Trends Immunol; 2004 Mar; 25(3):121-5. PubMed ID: 15036038
[No Abstract] [Full Text] [Related]
24. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
[TBL] [Abstract][Full Text] [Related]
25. New research in HIV immunity points way for vaccine.
Rees J
Expert Rev Clin Immunol; 2013 May; 9(5):403. PubMed ID: 23772447
[No Abstract] [Full Text] [Related]
26. Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines.
Steers NJ; Peachman KK; McClain S; Alving CR; Rao M
Vaccine; 2009 Nov; 27(49):6939-49. PubMed ID: 19748578
[TBL] [Abstract][Full Text] [Related]
27. AIDS research. Mystery anti-HIV factor unmasked?
Cohen J
Science; 2002 Sep; 297(5590):2188. PubMed ID: 12351761
[No Abstract] [Full Text] [Related]
28. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.
Li W; Li S; Hu Y; Tang B; Cui L; He W
Vaccine; 2008 Jun; 26(26):3282-90. PubMed ID: 18472194
[TBL] [Abstract][Full Text] [Related]
29. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.
Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG
J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415
[TBL] [Abstract][Full Text] [Related]
30. Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.
Cukalac T; Moffat JM; Venturi V; Davenport MP; Doherty PC; Turner SJ; Stambas J
Vaccine; 2009 Nov; 27(48):6755-61. PubMed ID: 19744584
[TBL] [Abstract][Full Text] [Related]
31. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
[TBL] [Abstract][Full Text] [Related]
32. Potential pitfalls on the road to an effective HIV vaccine.
Schwartz DH
Immunol Today; 1994 Feb; 15(2):54-7. PubMed ID: 7908803
[TBL] [Abstract][Full Text] [Related]
33. Is an HIV vaccine possible?
McMichael AJ; Hanke T
Nat Med; 1999 Jun; 5(6):612-4. PubMed ID: 10371492
[No Abstract] [Full Text] [Related]
34. Immunologic features of HIV-1-infected women on HAART at delivery.
Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385
[TBL] [Abstract][Full Text] [Related]
35. Vaccines. Vaccines as therapy.
TreatmentUpdate; 2005; 17(1):9-10. PubMed ID: 17228403
[No Abstract] [Full Text] [Related]
36. Developments in virus-like particle-based vaccines for HIV.
Buonaguro L; Tagliamonte M; Visciano ML; Tornesello ML; Buonaguro FM
Expert Rev Vaccines; 2013 Feb; 12(2):119-27. PubMed ID: 23414404
[TBL] [Abstract][Full Text] [Related]
37. Vaccines for HIV--looking to the future.
TreatmentUpdate; 2004 Oct; 16(6):1-3. PubMed ID: 17219677
[No Abstract] [Full Text] [Related]
38. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
39. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?
Egan MA
Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741
[No Abstract] [Full Text] [Related]
40. Rebuilding the immune system.
Averitt D
WORLD; 1999 Apr; (No 96):1-2. PubMed ID: 11366944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
